Table 2:
Treatment outcome.
| Variable | Complete Response (n=7) | Partial Response (n=23) | No Response (n=19) | Technical Failure (n=3) | P-value (excluding technical failure) |
|---|---|---|---|---|---|
| Demographics/Risk Factors | |||||
| Age | 33.1±9.2 | 37.9±10.8 | 36.2±11.8 | 37.8±1.03 | 0.60 |
| BMI | 25.4±5.7 | 26.9±6.5 | 28.4±5.5 | 27.0±4.9 | 0.49 |
| Symptoms (%) | |||||
| Chronic Pelvic Pain | 100 (59.0–100) | 100 (85.2–100) | 100 (82.4–100) | 100 | >0.99 |
| Dysmenorrhea | 71.4 (29.0–96.3) | 60.9 (38.5–80.3) | 47.4 (24.4–71.1) | 33.3 | 0.48 |
| Dyspareunia | 28.6 (3.7–71.0) | 69.6 (47.1–86.8) | 57.9 (33.5–79.7) | 33.3 | 0.15 |
| Back Pain | 28.6 (3.7–71.0) | 26.1 (10.2–48.4) | 31.6 (12.6–56.6) | 33.3 | 0.93 |
| Concomitant Diagnosis and Risk factors (%) | |||||
| Myofascial pain syndrome | 57.1 (18.4–90.1) | 54.5 (32.2–75.6) | 26.3 (9.1–51.2) | 33.3 | 0.14 |
| Endometriosis | 0.0 (0.0–41.0) | 26.1 (10.2–48.4) | 31.6 (12.6–56.6) | 0.0 | 0.24 |
| Fibromyalgia | 0.0 (0.0–41.0) | 8.7 (1.1–28.0) | 10.5 (1.3–33.1) | 0.0 | 0.68 |
| IBS | 14.3 (0.4–57.9) | 17.4 (5.0–38.8) | 16.7 (3.6–41.4) | 0.0 | 0.98 |
| Prior Pregnancy | 85.7 (42.1–99.6) | 87.0 (66.4–97.2) | 89.5 (66.9–98.7) | 100 | 0.96 |
| Prolonged Standing | 42.9 (9.9–81.6) | 43.5 (23.2–65.5) | 47.4 (24.4–71.1) | 33.3 | 0.96 |
| Imaging (%) | |||||
| Prior pelvic US | 57.1 (18.4–90.1) | 26.1 (10.2–48.4) | 36.8 (16.3–61.6) | 66.7 | |
| PCS on US review | 75.0 (19.4–99.4) | 33.3 (4.3–77.7) | 33.3 (4.3–77.7) | 50.0 | 0.35 |
| Prior pelvic CT | 28.6 (3.7–71.0) | 30.4 (13.2–52.9) | 26.3 (9.1–51.2) | 33.3 | |
| PCS on CT review | 0.0 (0.0–84.2) | 57.1 (18.4–90.1) | 80.0 (28.4–99.5) | 57.1 | 0.16 |
| Catheter Venographic Findings (%) | |||||
| Left Reflux/Dilation on venography | 85.7 (42.1–99.6) | 87.0 (66.4–97.2) | 89.5 (66.9–98.7) | 100 | 0.96 |
| Right Reflux/Dilation on venography | 57.1 (18.4–90.1) | 52.2 (30.6–73.2) | 42.1 (20.3–66.5) | 33.3 | 0.73 |
| Unilateral findings | 57.1 (18.4–90.1) | 56.5 (34.5–76.8) | 68.4 (43.4–87.4) | 66.7 | 0.71 |
| Bilateral findings | 42.9 (9.9–81.6) | 39.1 (19.7–61.5) | 31.6 (12.6–56.6) | 33.3 | 0.82 |
Treated subjects were separated based on outcome (partial, no response, complete response, or technical failure). Binary variables are summarized by percentage (95% confidence interval), while continuous variables are summarized as mean±standard deviation. Reported P-values are the results of the Chi-squared test for binary variables and ordinary one-way ANOVA for continuous variables. Pairwise comparisons for binary variables were performed using individual Fisher’s exact tests, with P-values corrected for FDR. Pairwise comparisons for continuous variables were performed using Tukey’s test. *No significant pairwise differences were found for any variables. BMI: Body mass index, CT: Computed tomography, PCS: Pelvic congestion syndrome, IBS: Irritable bowel syndrome